Table 2.
Coverage of human and pig treatment within 100-m rings around reported pigs
| Eligible houses (no.) | Eligible humans (no.) | Received one dose no. (%) | Received two doses no. (%) | Eligible pigs (no.) | Received one dose no. (%) |
|---|---|---|---|---|---|
| 8 | 31 | 24 (77.4) | 22 (71.0) | 33 | 24 (72.7) |
| 13 | 47 | 41 (87.2) | 37 (76.6) | 43 | 37 (86.0) |
| 11 | 43 | 35 (81.4) | 34 (79.1) | 24 | 18 (75.0) |
| 27 | 91 | 71 (75.0) | 62 (68.1) | 49 | 37 (75.5) |
| 18 | 32 | 28 (87.5) | 22 (69.0) | 27 | 19 (70.3) |
| 3 | 14 | 11 (78.6) | 8 (57.1) | 9 | 7 (77.6) |
| 5 | 18 | 17 (94.4) | 11 (61.1) | 26 | 18 (69.2) |
| 6 | 27 | 18 (66.7) | 16 (59.3) | 12 | 7 (58.3) |
| 8 | 26 | 22 (84.6) | 18 (60.2) | 27 | 21 (77.8) |
| 12 | 45 | 33 (68.8) | 27 (56.3) | 22 | 20 (90.9) |
| 7 | 24 | 15 (62.5) | 15 (62.3) | 9 | 7 (77.8) |
| 2 | 7 | 7 (100) | 7 (100) | 18 | 11 (61.1) |
| 8 | 42 | 36 (85.7) | 36 (85.7) | 24 | 7 (29.2) |
| 5 | 19 | 18 (94.7) | 18 (94.7) | 7 | 5 (71.4) |
| Total | 469 | 376 (80.1) | 332 (70.1) | 330 | 238 (72.1) |